By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Biothera 

3388 Mike Collins Drive

Eagan  Minnesota  55121  U.S.A.
Phone: 651-675-0300 Fax: 651-675-0400


SEARCH JOBS


Industry
Biotechnology






Company News
Biothera To Present New Data At International Cancer Immunotherapy Conference 9/1/2015 9:28:38 AM
Cancer Research UK Funding Preclinical Study With Biothera’s Imprime PGG in Combination Therapy 8/18/2015 10:17:07 AM
Investigator-Sponsored Trial Evaluating Biothera’s Imprime PGG In Relapsed Indolent Non-Hodgkin Lymphoma 6/22/2015 11:56:47 AM
Biothera To Participate In Webcast On Advances In Cancer Immunotherapy 6/18/2015 11:10:32 AM
ASCO15: Biothera Presents Additional Data At ASCO On Durability And Characteristics Of Response With Imprime PGG In Non-Small Cell Lung Cancer Study 6/1/2015 1:40:47 PM
Integrated Safety Data From Two Phase 2 Cancer Studies Demonstrates Biothera’s Investigational Cancer Immunotherapy Is Well Tolerated 6/1/2015 12:26:34 PM
ASCO15: Biothera Presents Additional Data At ASCO On Durability And Characteristics Of Response With Imprime PGG In Non-Small Cell Lung Cancer Study 6/1/2015 12:25:03 PM
Biothera Release: Imprime PGG-MAb Combination Therapy Achieves High Response Rate In Patients With Chronic Lymphocytic Leukemia 6/1/2015 11:34:03 AM
Biothera To Present Additional Data To The American Association Of Immunologists On Imprime PGG's Potential To Alleviate Tumor-Mediated Immunosuppression 5/8/2015 11:57:47 AM
Biothera’s Investigational Cancer Immunotherapy Alleviates Immune Suppression By Regulatory T Cells, Enabling CD4 And CD8 T Cell Proliferation, Study Finds 4/22/2015 8:45:21 AM
12345678910
//-->